Serum Prevalence of SARS-Cov-2 Antibodies in Pre-pandemic Blood Samples (SPARE)

Active, not recruitingOBSERVATIONAL
Enrollment

3,500

Participants

Timeline

Start Date

December 30, 2020

Primary Completion Date

October 18, 2023

Study Completion Date

December 30, 2024

Conditions
HealthyChronic Disease
Interventions
DIAGNOSTIC_TEST

Anti-COVID test

No intervention is foreseen by the protocol

Trial Locations (1)

00166

IRCCS San Raffaele, Rome

All Listed Sponsors
collaborator

Department of Transfusion Medicine Venice Area

UNKNOWN

collaborator

Istituto per lo Studio, la Prevenzione e la Rete Oncologica

OTHER

lead

IRCCS San Raffaele Roma

OTHER